Literature DB >> 16598393

Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes.

M Weber1, C Kleine, E Keil, M Rau, A Berkowitsch, A Elsaesser, V Mitrovic, C Hamm.   

Abstract

BACKGROUND: Recently it has been found that BNP and NT-proBNP provide independent prognostic information in patients with acute coronary syndromes (ACS). However, little data are available on the time course of NT-proBNP levels in relation to onset of symptoms. METHODS AND
RESULTS: We included 765 patients (236 females, aged 64 +/- 11 years) with an ACS (STEMI 42%, NSTEMI 41%, UAP 17%), who were referred for coronary angiography. NT-proBNP was assessed on admission and the next day. NT-proBNP values were related to the time duration from onset of symptoms until blood drawing with lowest values within 3 h and highest values 24-36 h after onset of symptoms (147 (64-436) pg/ml and 1099 (293-3795) pg/ml, respectively, p < 0.001). Highest values for NT-proBNP on admission were found in patients with NSTEMI compared to patients with STEMI and UAP (912 (310-2258) pg/ml) vs 262 (85-1282) pg/ml) vs 182 (74- 410) pg/ml; p < 0.001), but no difference was present between STEMI and NSTEMI the day after admission (1325 (532-2974) pg/ ml vs 1169 (555-3413) pg/ml; p = 0.676). In contrast NT-proBNP values remained unchanged in UAP (182 (74-410) pg/ml) vs 171 (53-474) pg/ml).
CONCLUSION: The time interval from onset of symptoms to first blood collection is an important determinant for NT-proBNP values on admission in patients with an ACS and needs to be considered in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598393     DOI: 10.1007/s00392-006-0375-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   6.138


  32 in total

Review 1.  The natriuretic peptides.

Authors:  Gary F Baxter
Journal:  Basic Res Cardiol       Date:  2004-01-23       Impact factor: 17.165

Review 2.  A classification of unstable angina revisited.

Authors:  C W Hamm; E Braunwald
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

3.  Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.

Authors:  Denzil Gill; Timothy Seidler; Richard W Troughton; Timothy G Yandle; Christopher M Frampton; Mark Richards; John G Lainchbury; Gary Nicholls
Journal:  Clin Sci (Lond)       Date:  2004-02       Impact factor: 6.124

4.  [Brain-natriuretic-peptide (BNP) for improvement of the diagnostic determination in a conserving emergency room].

Authors:  F Post; D Peetz; P Knoess; H-J Rupprecht
Journal:  Z Kardiol       Date:  2004

5.  Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.

Authors:  Franz Hartmann; Milton Packer; Andrew J S Coats; Michael B Fowler; Henry Krum; Paul Mohacsi; Jean L Rouleau; Michal Tendera; Alain Castaigne; Stefan D Anker; Ildiko Amann-Zalan; Silke Hoersch; Hugo A Katus
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

6.  B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Authors:  Kirsten Bibbins-Domingo; Maria Ansari; Nelson B Schiller; Barry Massie; Mary A Whooley
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

7.  Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro.

Authors:  P Mäntymaa; O Vuolteenaho; M Marttila; H Ruskoaho
Journal:  Endocrinology       Date:  1993-09       Impact factor: 4.736

8.  N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.

Authors:  Michael Weber; Thorsten Dill; Roman Arnold; Matthias Rau; Okan Ekinci; Klaus D Müller; Alexander Berkovitsch; Veselin Mitrovic; Christian Hamm
Journal:  Am Heart J       Date:  2004-10       Impact factor: 4.749

9.  Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.

Authors:  Michael Weber; Roman Arnold; Matthias Rau; Roland Brandt; Alexander Berkovitsch; Veselin Mitrovic; Christian Hamm
Journal:  Am J Cardiol       Date:  2004-09-15       Impact factor: 2.778

10.  Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes.

Authors:  T Tanaka; T Kanda; T Takahashi; S Saegusa; J Moriya; M Kurabayashi
Journal:  J Int Med Res       Date:  2004 Jan-Feb       Impact factor: 1.671

View more
  8 in total

1.  Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study.

Authors:  David M Leistner; Jens Klotsche; Lars Pieper; Sylvia Palm; Günter K Stalla; Hendrik Lehnert; Sigmund Silber; Winfried März; Hans-Ulrich Wittchen; Andreas M Zeiher
Journal:  Clin Res Cardiol       Date:  2013-01-04       Impact factor: 5.460

2.  Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.

Authors:  Antonio Ruggiero; Gabriella De Rosa; Daniela Rizzo; Andrea Leo; Palma Maurizi; Alessia De Nisco; Francesca Vendittelli; Cecilia Zuppi; Alvaro Mordente; Riccardo Riccardi
Journal:  Int J Clin Oncol       Date:  2012-08-22       Impact factor: 3.402

3.  Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).

Authors:  M Möckel; R Müller; J O Vollert; C Müller; O Danne; R Gareis; T Störk; R Dietz; W Koenig
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

4.  Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.

Authors:  Fotiní Dodos; Teresa Halbsguth; Erland Erdmann; Uta C Hoppe
Journal:  Clin Res Cardiol       Date:  2008-01-14       Impact factor: 5.460

Review 5.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

6.  Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy.

Authors:  Paweł Stachowiak; Zdzisława Kornacewicz-Jach; Krzysztof Safranow
Journal:  Arch Med Sci       Date:  2013-04-30       Impact factor: 3.318

7.  Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?

Authors:  Evrim Eylem Akpınar; Derya Hoşgün; Serdar Akpınar; Can Ateş; Ayşe Baha; Esen Sayın Gülensoy; Nalan Ogan
Journal:  J Bras Pneumol       Date:  2019-08-12       Impact factor: 2.624

8.  Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial.

Authors:  Martin Marinšek; Andreja Sinkovič
Journal:  Biomed Res Int       Date:  2016-03-15       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.